TD

Tejas Deepak Naphade

Active Director Director DIN 10219144
DIN 10219144 First appointment Jul 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Jul 2023
Shareholding value •••• Premium profile

About Tejas Deepak Naphade

Data last updated:

Tejas Deepak Naphade is a Director at Quality Care India Limited (since 2023) and Nominee Director at International Gemological Institute Limited (since 2023). The companies operate in Healthcare, Education and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹2,124 Cr; the largest is Quality Care India Limited at ₹1,624 Cr (FY 2023). Earlier, Tejas Deepak Naphade was a Director at United Ciigma Institute Of Medical Sciences Private Limited (2023–2025) and Nominee Director at Condis India Healthcare Private Limited (2024) and 1 more.

DIN 10219144
Primary Designation Director
Industry Healthcare
First Appointment 26 Jul 2023
Oldest Company Age 34 yrs
Largest company Quality Care India Limited · ₹1,624 Cr (FY 2023)
Combined revenue ₹2,124 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Quality Care India Limited U85110TG1992PLC014728
Director27 Oct 20231992₹1,624 Cr (FY 2023)Active
Nominee Director26 Jul 20231999₹500 Cr (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Nov 20232011₹147 Cr (FY 2025)Active
Nominee Director23 Jan 20242006₹1,286 Cr (FY 2025)Amalgamated
Kims Health Care Management Limited U85110KL1995PLC009336
Nominee Director23 Jan 20241995₹1,282 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
International Gemological Institute Limited
Quality Care India Limited
United Ciigma Institute Of Medical Sciences Private Limited
Condis India Healthcare Private Limited
Premium access

Shareholding and investment profile for Tejas Deepak Naphade

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tejas Deepak Naphade

Tejas Deepak Naphade currently holds 2 directorships: Quality Care India Limited (Director, since 27 Oct 2023, revenue ₹1,624 Cr (FY 2023)); International Gemological Institute Limited (Nominee Director, since 26 Jul 2023, revenue ₹500 Cr (FY 2023)).

Tejas Deepak Naphade was first appointed on 26 Jul 2023 as Nominee Director at International Gemological Institute Limited. The most recent appointment on record is 23 Jan 2024 at Kims Health Care Management Limited.

The 2 current companies of Tejas Deepak Naphade that report revenue have a combined latest revenue of ₹2,124 Cr: Quality Care India Limited ₹1,624 Cr (FY 2023); International Gemological Institute Limited ₹500 Cr (FY 2023).

Tejas Deepak Naphade held 3 earlier board appointments: United Ciigma Institute Of Medical Sciences Private Limited (Director, 17 Nov 2023 to 20 Nov 2025); Condis India Healthcare Private Limited (Nominee Director, 23 Jan 2024 to 26 Jun 2024); Kims Health Care Management Limited (Nominee Director, 23 Jan 2024 to 26 Jun 2024).

The current boards of Tejas Deepak Naphade's companies include Aniket Damle (Quality Care India Limited), Ayshwarya Ravi Vikram (Quality Care India Limited), Ekta Bahl (Quality Care India Limited), Ganesh Mani (Quality Care India Limited), Gayathri Sathanoor Chandramoulieswaran (Quality Care India Limited), Himanshu Dodeja (Quality Care India Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available